Neurointerventional Devices Market to Reach $5.3 Billion, Globally, by 2032 at 7.5% CAGR: Allied Market Research

The global neurointerventional devices market is driven by the surge in prevalence of neurological and disorders, rise in preference towards minimally invasive procedures, and rise in awareness of neurological disorders among general population.

PORTLAND, Ore., July 24, 2023 /PRNewswire/ -- Allied Market Research published a report, titled, "Neurointerventional Devices Market by Product (Catheter, Wires, Stents, Embolic Coils, and Others), Indication (Brain Aneurysm, Stroke, and Others), and End User (Hospitals and Ambulatory Surgical Center): Global Opportunity Analysis and Industry Forecast, 2023-2032". According to the report, the global neurointerventional devices market industry generated $2.54 billion in 2022 and is estimated to reach $5.26 billion by 2032, exhibiting a CAGR of 7.5% from 2023 to 2032.

Request Sample of the Report on Neurointerventional Devices Market Analysis 2032- Allied Market Research- https://www.alliedmarketresearch.com/request-sample/14825 

Prime determinants of growth

The growth of the neurointerventional devices market is fueled by the increasing prevalence of neurological disorders, a growing preference for minimally invasive procedures, and the rising awareness of neurological disorders among the general population. However, high cost of neurointerventional devices is projected to impede the market growth in upcoming years. Moreover, technological advancements in neurointerventional devices presents new opportunities in the coming years.

Report coverage & details:

Procure Complete Report (282 Pages with Insights, Charts, Tables, and Figures)
https://www.alliedmarketresearch.com/checkout-final/neurointerventional-devices-market

Covid-19 Scenario

• The outbreak of the Covid-19 pandemic had a negetive impact on the global neurointerventional devices market, owing to overwhelming number of COVID-19 cases, hospitals and healthcare facilities faced a significant burden, leading to the reallocation of resources for pandemic management. As a result, non-emergency procedures such as neurointerventional interventions had to be postponed or canceled in order to prioritize the care of COVID-19 patients..
• Restrictions on movement and lockdown measures in numerous countries resulted in a reduction in the number of patients visiting hospitals and clinics for regular check-ups and elective treatments. This decrease in patient visits had a direct effect on the demand for neurointerventional devices, as there was a significant decline in the number of procedures being performed.
• As the pandemic gradually diminishes and vaccinations become more widespread, neurointerventional devices market recovered significantly. Delayed cases and postponed elective procedures were addressed, leading to a surge in patient volumes for these interventions.

The catheter segment to maintain its leadership status throughout the forecast period

Based on product, the catheter segment held the highest market share in 2022 and is expected to remain dominant during the forecasted period, accounting for one third of the global neurointerventional devices market revenue. The same segment is expected to witness the fastest CAGR of 8.4% during theforecasted period. This is attributed to catheter being used in various neurointerventional procedures, including diagnostic imaging, embolization, angioplasty, and thrombectomy.

The stroke segment maintains its leadership status throughout the forecast period

Based on indication, the stroke segment held the highest market share in 2022, accounting for more than half of the global neurointerventional devices market revenue.The same segment is expected to witness the fastest CAGR of 7.8% during theforecasted period, owing to high prevalence of stroke.

The ambulatory surgical centers segment registered largest revenue share in 2022

By applications, ambulatory surgical centers held the highest market share in 2022, accounting for nearly half of the global neurointerventional devices market revenue, owing to the reason that ambulatory surgical centers have lower overhead costs, reduced length of stay, and streamlined processes, which can result in significant cost savings for both patients and healthcare providers. However, hospitals segment is expected to register fastest CAGR of 7.8% during the forecasted period, owing to the reason that hospitals generally have the necessary infrastructure and resources to support neurointerventional procedures.

For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/14825 

North America segment emerged as highest revenue generator.

Based on region, North America held the highest market share in terms of revenue in 2022, accounting for more than one-third of the global neurointerventional devices market market revenue, This can be attributed to technological advancements in the healthcare sector, increased adoption of minimally invasive procedures, a growing elderly population, and the strong presence of key market players in the region. However, the Asia-Pacific region is expected to witness the fastest CAGR of 8.3% during the forecasted period owing to the rise in medical tourism and an increase in the prevalence of neurological disorders.

Leading Market Players: -

• Johnson & Johnson
• Lepu Medical Technology (Beijing) Co., Ltd
• Integer Holdings Corporation
• Medtronic plc
• Terumo Corporation
• Merit Medical Systems Inc.
• Balt Group
• Stryker Corporation.
• Penumbra, Inc
• Cook Group Inc

The report provides a detailed analysis of these key players in the neurointerventional devices market market. These players have adopted new acquisition, expansion and product launch as strategy to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario. 

Trending Reports in Healthcare Industry-

 Bone Grafts and Substitutes Market - Global Opportunity Analysis and Industry Forecast, 2022-2032

Companion Diagnostic Market - Global Opportunity Analysis and Industry Forecast, 2022–2032

Infant Incubator Market- Global Opportunity Analysis and Industry Forecast, 2022–2032

Influenza Vaccine Market- Global Opportunity Analysis and Industry Forecast, 2022–2032

Alopecia Treatment Market - Global Opportunity Analysis and Industry Forecast, 2022–2032

Pneumonia Vaccine Market- Global Opportunity Analysis and Industry Forecast, 2022–2032

Empty Capsules Market - Global Opportunity Analysis and Industry Forecast, 2022–2032

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

"We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market."

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220                                                            
United States
Toll Free: +1-800-792-5285                                                         
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
[email protected]
Web: https://www.alliedmarketresearch.com  
Follow Us on: LinkedIn Twitter

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg

SOURCE Allied Market Research